U-Chart Analysis:TOWA PHARMACEUTICAL CO.,LTD.:4553

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TOWA PHARMACEUTICAL CO.,LTD. Go to web site 4553 Medicals 東証プライム March 1, 2000 1994.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 24,257 32,830 22,915 18,713 26,762
Other Current AssetsHelp 158,733 134,034 114,375 102,812 81,444
Tangible Fixed AssetsHelp 127,004 99,873 85,898 81,629 73,663
Intangible Fixed AssetHelp 18,332 18,999 7,913 7,912 1,470
Investments and OthersHelp 43,021 46,361 -20,046 -20,114 -1,586
Total AssetsHelp 371,347 332,097 245,668 230,016 188,803
Total Current LiabilitiesHelp 84,139 120,734 54,971 73,687 38,590
Total Long-term LiabilitiesHelp 150,314 79,194 74,098 51,664 58,442
Shareholder's EquityHelp 136,894 132,169 116,599 104,665 91,771
Total LiabilitiesHelp 371,347 332,097 245,668 230,016 188,803

TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 208,859 165,615 154,900 110,384 105,104
Total Sales 208,859 165,615 154,900 110,384 105,104
Cost of SalesHelp 136,145 95,429 89,448 59,738 56,705
Other Costs and RevenueHelp 70,513 54,271 51,494 36,143 34,923
Total CostsHelp 206,658 149,700 140,942 95,881 91,628
Net RevenueHelp 72,714 70,186 65,452 50,646 48,399
Earnings Before TaxHelp 4,605 22,246 18,728 20,709 18,886
Net IncomeHelp 2,201 15,915 13,958 14,503 13,476
Net Income 2,201 15,915 13,958 14,503 13,476

TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 2,545 22,129 12,354 19,166 19,001
Investing Cash Flow(ICF)Help -30,284 -59,729 -9,100 -39,541 -3,994
Financing Cash FlowHelp 17,481 46,540 184 11,748 -809
Exchange Difference of Cash and Cash EquivalentsHelp 1,685 975 761 689 943
Net Increase and Decrease in Cash and Cash Equivalentsn -8,573 9,915 4,199 -7,938 15,141

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TOWA PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Fuso Pharmaceutical Industries, Ltd.
ECI,Inc.
Astellas Pharma Inc.
NIPPON CHEMIPHAR CO.,LTD.
Noile-Immune Biotech Inc.
Eisai Co.,Ltd.
OncoTherapy Science,Inc.
SAWAI PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
TMS Co.,Ltd.